Research Article

Correlation between Blood Activin Levels and Clinical Parameters of Type 2 Diabetes

Table 3

Associations between circulating levels of activin B and demographic and biochemical indices within subject groups.

Total subjectsNormalIFG/IGTT2D

Age 0.100−0.2060.2670.159
BMI 0.1700.0920.3210.201
Smoking0.1600.0290.3560.200
Fasting glucose0.298**,†0.0720.0800.406*
HbA1c 0.331**,†−0.1930.2920.529**
Fasting insulin0.254*0.0510.510*0.293
HOMA-IR0.332**,†0.0560.514*0.426*,†
AUCg−0.1000.066−0.155−0.274
Crcl0.0090.098−0.1210.004
HsCRP0.1200.021−0.243−0.119
Follistatin 0.0260.008−0.0100.033

BMI: body mass index; HbA1c: glycated hemoglobin; HOMA-IR: homeostasis model assessment of insulin resistance; AUCg: area under the curve for OGTT glucose levels; Crcl: creatinine clearance; HsCRP: human sensitive C-reactive protein. Data presented as univariate Pearson correlation coefficients ( ) value: * , ** . Correlations with no superscript are not significant ( ). After adjustment for confounding factors (including age, BMI, history of smoking, history of hypertension and medication use, blood pressure parameters) by multivariate analysis, activin retained a positive association among total subjects with fasting glucose, HbA1c, and HOMA-IR but lost its correlation with fasting insulin. In the T2D group, only HOMA-IR retained a positive correlation with activin after adjustment.